Efficacy And Safety Of Dihydrotestosterone (DHT) To Prevent Prostate Growth In Middle-Aged Men

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000358640

Enrollment

100

Registered

2005-09-09

Start date

2004-07-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dihydrotestoerone for 2 years.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

Male

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

Generally healthy men over age 50 years of age without known prostate disease.

Exclusion criteria

No exclusion criteria

Outcome results